William Ellis
Cardiovascular Disease · Thomasville, GANPI 1073515300
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,242 of the $4,534 with a category attached, or 71.5%. 25 manufacturers reported payments, led by Penumbra, Inc. at 37.2% of the total. 2025 is the largest year on record at $2,037, 2.6 times the $782 reported in 2019.
Across 190 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Novartis$702
- Pfizer$349
- Amgen$292
- Johnson & Johnson$267
- Abbott$206
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,25928%
- Food & beverage$3,24272%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 5 | $1,688 |
| Novartis | 53 | $702 |
| Pfizer | 28 | $349 |
| Amgen | 18 | $292 |
| Johnson & Johnson | 15 | $267 |
| Abbott | 5 | $206 |
| Merck | 12 | $194 |
| E.r. Squibb & Sons, L.L.C. | 7 | $88 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $81 |
| Kowa Pharmaceuticals America, Inc. | 5 | $75 |
| Arbor Pharmaceuticals, Inc. | 4 | $59 |
| Amarin Pharma, Inc. | 3 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Novo Nordisk | 3 | $47 |
| Medtronic | 3 | $45 |
| Boehringer Ingelheim | 2 | $43 |
| Boston Scientific | 2 | $33 |
| Itamar Medical Inc | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| AstraZeneca | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Bayer | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,624
- ESPRIT$132
- XARELTO$114
How this compares
$4,534 in reported general payments places this provider in the 65th percentile of 640 cardiovascular disease providers in Georgia.
Other cardiovascular disease in Thomasville
- Kashyap ChoksiThomasville$263K
- Narendra SinghJohns Creek$1.6M
- Hunter ChampionColumbus$1.5M
- Nicolas ChronosEatonton$912K
- Jaime BurkleGainesville$628K
- Joseph MillerAtlanta$573K
- Utpal PandyaAtlanta$221K
- Randolph MartinAtlanta$177K
- Hiren ShahColumbus$166K
- Mani VannanAtlanta$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.